|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.52 EUR | +0.14% |
|
+0.64% | -28.80% |
| Jul. 14 | German Equities Close Higher; US-Iran Tensions Flare | MT |
| Jul. 14 | CARL ZEISS MEDITEC AG : Deutsche Bank reiterates its Neutral rating | ZD |
Company Valuation: Carl Zeiss Meditec AG
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 14,852 | 9,610 | 7,407 | 6,364 | 3,691 | 2,493 | - | - |
| Change | - | -35.29% | -22.92% | -14.09% | -42.01% | -32.45% | - | - |
| Enterprise Value (EV) 1 | 14,016 | 8,823 | 6,683 | 6,378 | 3,967 | 2,929 | 2,888 | 2,807 |
| Change | - | -37.05% | -24.26% | -4.56% | -37.8% | -26.18% | -1.39% | -2.81% |
| P/E | 62.9x | 32.7x | 25.5x | 35.4x | 26.2x | 29.6x | 20x | 14.5x |
| PBR | 8.95x | 4.77x | 3.43x | 3.1x | 1.74x | 1.17x | 1.12x | 1.06x |
| PEG | - | 1.3x | -20.97x | -0.9x | -1.3x | -0.7x | 0.4x | 0.4x |
| Capitalization / Revenue | 9.02x | 5.05x | 3.55x | 3.08x | 1.66x | 1.14x | 1.09x | 1.03x |
| EV / Revenue | 8.51x | 4.64x | 3.2x | 3.09x | 1.78x | 1.34x | 1.26x | 1.15x |
| EV / EBITDA | 32.2x | 18.9x | 15.8x | 19.5x | 11.3x | 10.2x | 8.45x | 7.14x |
| EV / EBIT | 37.5x | 22.2x | 19.2x | 32.8x | 17.8x | 18.9x | 13.8x | 10.6x |
| EV / FCF | 42.1x | 60.7x | 48.8x | 67.1x | 29.8x | 37.6x | 23.5x | 16.5x |
| FCF Yield | 2.37% | 1.65% | 2.05% | 1.49% | 3.36% | 2.66% | 4.25% | 6.04% |
| Dividend per Share 2 | 0.9 | 1.1 | 1.1 | 0.6 | 0.55 | 0.4529 | 0.5739 | 0.7441 |
| Rate of return | 0.54% | 1.02% | 1.33% | 0.84% | 1.3% | 1.59% | 2.01% | 2.61% |
| EPS 2 | 2.64 | 3.29 | 3.25 | 2.01 | 1.61 | 0.963 | 1.421 | 1.967 |
| Distribution rate | 34.1% | 33.4% | 33.8% | 29.9% | 34.2% | 47% | 40.4% | 37.8% |
| Net sales 1 | 1,647 | 1,903 | 2,089 | 2,066 | 2,228 | 2,183 | 2,296 | 2,432 |
| EBITDA 1 | 435.2 | 466.6 | 422.2 | 327.2 | 349.7 | 286 | 342 | 392.9 |
| EBIT 1 | 373.6 | 396.9 | 348.1 | 194.5 | 223.3 | 154.7 | 209.8 | 264.6 |
| Net income 1 | 236.3 | 293.9 | 290.4 | 178.7 | 141.2 | 90.99 | 136.1 | 179.6 |
| Net Debt 1 | -835.5 | -787.4 | -724.9 | 14.4 | 276.9 | 435.9 | 395.2 | 314 |
| Reference price 2 | 166.05 | 107.45 | 82.82 | 71.15 | 42.16 | 28.48 | 28.48 | 28.48 |
| Nbr of stocks (in thousands) | 89,441 | 89,441 | 89,441 | 89,441 | 87,536 | 87,536 | - | - |
| Announcement Date | 12/10/21 | 12/9/22 | 12/12/23 | 12/10/24 | 12/10/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.57x | 1.34x | 10.24x | 1.59% | 2.85B | |
| 26.74x | 4.8x | 18.5x | 0.35% | 198B | |
| 41.97x | 10.88x | 24.33x | -.--% | 134B | |
| 32.21x | 6.24x | 19.63x | 0.72% | 141B | |
| 15.66x | 3.27x | 10.53x | -.--% | 63.36B | |
| 32.12x | 7.17x | 22.81x | -.--% | 51.87B | |
| 18.18x | 2.1x | 10.88x | 2.89% | 43.77B | |
| 26.29x | 5.24x | 17.89x | 0.76% | 38.18B | |
| 45.62x | 6.37x | 19.56x | -.--% | 36.96B | |
| 13.86x | 1.56x | 8.73x | 0.25% | 28.05B | |
| Average | 28.22x | 4.90x | 16.31x | 0.66% | 73.88B | |
| Weighted average by Cap. | 29.92x | 6.02x | 18.56x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AFX Stock
- Valuation Carl Zeiss Meditec AG
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
